Phibro Animal Health

$21.75 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company's Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.

Stock Analysis

last close $21.8
1-mo return 2%
3-mo return -12.7%
avg daily vol. 108.57T
52-week high 31
52-week low 16.27
market cap. $443M
forward pe 17
annual div. 0.48
roe 25.5%
ltg forecast -
dividend yield 2.2%
annual rev. $833M
inst own. -
baraka

Subscribe now for daily local and international financial news

Subscribe